Literature DB >> 31127021

Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.

Ming-Da Wang1, Chao Li1, Jun Li1, Wan-Guang Zhang2, Wei-Qin Jiang3, Jiong-Jie Yu1, Hao Xing1, Han Wu1, Jun Han1, Zhen-Li Li1, Xin-Fei Xu1, Ting-Hao Chen4, Ya-Hao Zhou5, Wei-Min Gu6, Hong Wang7, Yong-Yi Zeng8, Yao-Ming Zhang9, Timothy M Pawlik10, Wan Yee Lau1,11, Meng-Chao Wu1, Jia-Mei Yang1, Feng Shen12, Tian Yang12.   

Abstract

BACKGROUND: The long-term prognosis after liver resection for multinodular (≥3 nodules) hepatocellular carcinoma (HCC) is generally considered to be unfavorable. However, the role of liver resection for binodular HCC is less investigated. SUBJECTS, MATERIALS, AND METHODS: From a multicenter database, consecutive patients who underwent curative-intent liver resection for binodular HCC and without macrovascular invasion between 2003 and 2015 were retrospectively reviewed. Patients' clinical variables as well as perioperative and long-term survival outcomes were analyzed. Univariable and multivariable analyses were performed to identify the risk factors associated with overall survival (OS) and recurrence-free survival (RFS) after curative resection.
RESULTS: Of 263 enrolled patients, the perioperative 30-day mortality and morbidity rates were 1.5% and 28.5%. The 1-, 3-, and 5-year OS and RFS rates were 81.5%, 52.4%, and 39.1% and 57.1%, 35.8%, and 26.6%, respectively. Multivariable Cox-regression analyses identified preoperative alpha-fetoprotein level >400 μg/L, tumor size with a sum of two nodules >8 cm, tumor size ratio of large/small nodule >1.5 (asymmetrical proportion), unilateral hemiliver distribution of two nodules, distance of ≤3 cm between two nodules, and microvascular invasion in any nodule as independent risk factors associated with decreased OS and RFS.
CONCLUSION: Liver resection was safe and feasible in patients with binodular HCC, with acceptable perioperative and long-term outcomes. Sum of two tumor sizes, size ratio and distribution, and distance between two nodules were independent risk factors associated with long-term survival outcomes after surgery. These results may guide clinicians to make individualized surgical decisions and estimate long-term prognosis for these patients. IMPLICATIONS FOR PRACTICE: Liver resection was safe and feasible in patients with binodular hepatocellular carcinoma, with acceptable perioperative and long-term outcomes. The sum of two tumor sizes, the size ratio and distribution of the two nodules, and the distance between two nodules were independent risk factors associated with long-term overall survival and recurrence-free survival after liver resection. The results of this study may guide clinicians to make individualized surgical decisions, estimate long-term prognosis, and plan recurrence surveillance and adjuvant therapy for these patients. © AlphaMed Press 2019.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Intrahepatic metastasis; Multicentric origin; Overall survival; Recurrence‐free survival

Year:  2019        PMID: 31127021      PMCID: PMC6693721          DOI: 10.1634/theoncologist.2018-0898

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  31 in total

1.  Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma.

Authors:  T Utsunomiya; M Shimada; K I Taguchi; H Hasegawa; Y Yamashita; T Hamatsu; S I Aishima; K Sugimachi
Journal:  J Am Coll Surg       Date:  2000-03       Impact factor: 6.113

2.  Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.

Authors:  Ya-Wen Lin; Hsuan-Shu Lee; Chien-Hung Chen; Guan-Tarn Huang; Po-Huang Lee; Jin-Chuan Sheu
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

3.  Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics.

Authors:  Masato Sakon; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Koji Umeshita; Takamichi Murakami; Hironobu Nakamura; Morito Monden
Journal:  Arch Surg       Date:  2002-01

4.  Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.

Authors:  Kelvin K Ng; Jean-Nicolas Vauthey; Timothy M Pawlik; Gregory Y Lauwers; Jean-Marc Regimbeau; Jacques Belghiti; Iwao Ikai; Yoshio Yamaoka; Steven A Curley; David M Nagorney; Irene O Ng; Sheung Tat Fan; Ronnie T Poon
Journal:  Ann Surg Oncol       Date:  2005-03-31       Impact factor: 5.344

Review 5.  Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance.

Authors:  Y Matsumoto; H Fujii; M Matsuda; H Kono
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

Review 6.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

7.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Hiroshi Imamura; Yutaka Matsuyama; Eiji Tanaka; Takao Ohkubo; Kiyoshi Hasegawa; Shinichi Miyagawa; Yasuhiko Sugawara; Masami Minagawa; Tadatoshi Takayama; Seiji Kawasaki; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083

8.  Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin.

Authors:  H Tsuda; T Oda; M Sakamoto; S Hirohashi
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

9.  Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor.

Authors:  Siu Tim Cheung; Xin Chen; Xin Yuan Guan; San Yu Wong; Lai Shan Tai; Irene O L Ng; Samuel So; Sheung Tat Fan
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

Review 1.  Treatment Options for Early-Stage Hepatocellular Carcinoma.

Authors:  Nora E Tabori; Gajan Sivananthan
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

2.  Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.

Authors:  Lei Liang; Bing Quan; Han Wu; Yong-Kang Diao; Jie Li; Ting-Hao Chen; Yao-Ming Zhang; Ya-Hao Zhou; Wan-Guang Zhang; Hong Wang; Matteo Serenari; Matteo Cescon; Myron Schwartz; Yong-Yi Zeng; Ying-Jian Liang; Hang-Dong Jia; Hao Xing; Chao Li; Ming-Da Wang; Wen-Tao Yan; Wan-Yuan Chen; Wan Yee Lau; Cheng-Wu Zhang; Timothy M Pawlik; Dong-Sheng Huang; Feng Shen; Tian Yang
Journal:  Hepatol Int       Date:  2021-02-03       Impact factor: 6.047

3.  Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).

Authors:  Lei Liang; Ming-Da Wang; Yao-Ming Zhang; Wan-Guang Zhang; Cheng-Wu Zhang; Wan Yee Lau; Feng Shen; Timothy M Pawlik; Dong-Sheng Huang; Tian Yang
Journal:  J Hepatocell Carcinoma       Date:  2021-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.